Human Vaccines

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Development of a survey to identify vaccine-hesitant parents

  Citation: 355

  Authors: Douglas J., Rita, James A., Carolyn, Cheryl, Sheryl, Diane P.

• Comparison of the immunogenicity and safety of<i>Cervarix</i>â„¢ and<i>Gardasil</i>^®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years

  Citation: 316

  Authors: Mark H., Mira, Myron J., Archana, Robert P., Fred, Isabelle, Francis J., Andrew F., Anne, Gary

• Development of a metabolically active, non-replicating sporozoite vaccine to prevent<i>Plasmodium falciparum</i>malaria

  Citation: 243

  Authors: Stephen L., Peter F., Eric, Adam, Mark, Tao, Sumana, Anusha, Rana, Minglin, Richard, Adriana, Judith E., Martha, Sharina, Thomas L., Kirsten E., Robert, Matthew, Christopher V., B. Kim Lee

• From the circumsporozoite protein to the RTS,S/AS candidate vaccine

  Citation: 213

  Authors: Joe, Victor, Johan, Amanda

• Clinical development of plant-produced recombinant pharmaceuticals: Vaccines, antibodies and beyond

  Citation: 196

  Authors: Vidadi, Stephen J., Natasha

• Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

  Citation: 179

  Authors: Sven-Eric, Susanne K., Kristján, Ole-Erik, Mauricio, Cosette M., Gonzalo, Darron R., Laura A., Eng, Patricia, Kevin A., Suzanne M., Sepp, Grace W.K., Daron G., Jorma, Jorma, Marc, F. Xavier, Joakim, Elmar, Slawomir, Nubia, Evan R., Luisa L.

• Prime-boost vectored malaria vaccines: Progress and prospects

  Citation: 176

  Authors: Adrian V. S., Arturo, Geraldine, Katie, Alison, Anna, Alfredo, Antonella, Stefano, Riccardo, Sarah C., Simon

• Performance of rotavirus vaccines in developed and developing countries

  Citation: 175

  Authors: Victoria, Baoming, Jacqueline, Umesh D., Manish M.

• Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule

  Citation: 158

  Authors: Barbara, Tino F., Linda M., Klaus, Marc, Karin, Brian, Peter, Grégory, Kurt, Anne, Dominique

• Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVaxâ„¢-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All

  Citation: 157

  Authors: Farshad, Scott, Dennis, Remi, Karen, Richard, Sutee, Xiaochu, Thomas H., Niranjan, Philip, Jean, Marie-Jose, Thomas P.